Clinical studies have found a correlation between APOE ε4 and more severe tau pathology, neurodegeneration, and memory impairment in AD patients (Filippini et al., 2009; Therriault et al., 2020; Wang Y.-T. Here, MAPT is linked to Alzheimer disease.